U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261761) titled 'Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy' on Nov. 19.
Brief Summary: intervention eligible patients with teeth diagnosed with reversible or irreversible pulpits will go for vital pulp therapy and the other group will be patients will go for extraction of caries free teeth for orthodontic reasons, blood samples will be collected from both groups to analyze the level of cytokines IL-8 and IL-10 and it's relation with the success of the pulp therapy
Study Start Date: Oct. 01, 2022
Study Type: INTERVENTIONAL
Condition:
Reversible Pulpitis
Irreversible Pulpitis
Inter...